A Phase I/Ⅱ Randomized Controlled Proof-of-concept Study to Evaluate the Safety and Efficacy of JINZHEN Granules for Oral Solution in Participants With Mild to Moderate COVID-19
JINZHEN is a botanical drug that contains eight chemical constituents extracted from plant, mineral and animal origin raw materials. This study is to evaluate the safety and efficacy of JINZHEN Granules for Oral Solution compared to placebo for treatment of mild to moderate COVID-19 outpatients.
Treatment of Primary Dysmenorrhea With Kanion Capsule (GF) A Randomized, Double-blind, Placebo-controlled, Repeated-Dose and Multi-Center Clinical Phase II Trial
The objectives of this clinical trial are:
To further study the safety of Kanion Capsule (GF) in primary dysmenorrhea subjects;
To further evaluate the efficacy of GF in treatment of primary dysmenorrhea.
100 Clinical Results associated with Lianyungang Kanion Pharmaceutical Commerce Co.
0 Patents (Medical) associated with Lianyungang Kanion Pharmaceutical Commerce Co.
100 Deals associated with Lianyungang Kanion Pharmaceutical Commerce Co.
100 Translational Medicine associated with Lianyungang Kanion Pharmaceutical Commerce Co.